Back to search
Subclinical Hypercortisolism
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Subclinical Hypercortisolism trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Subclinical Hypercortisolism trials you may qualify forThe goal of this study is to learn how two treatments-adrenalectomy (surgical removal of an adrenal gland) and semaglutide (a medication used for weight managem…
To characterize the impact of Isturisa on clinical features and comorbidities associated with MACS. The investigators hypothesize that patients treated with Ist…
Drug interventional, controlled, randomized open-label, parallel-group, multicenter study in patients with bilateral adrenal incidentalomas associated with subc…
The human gut microbiome has been associated with many health factors but variability between studies limits the exploration of effects between them. This study…
Incidental findings of adrenal tumours,"incidentalomas", occur in 1-5 % in the general population and 10-25 % of these patients will exhibit biochemical mild hy…
The general objective is to evaluate the consequences of surgical removal of SCSI on hypertension and cardiovascular risk factors in order to determine on an ev…
The purpose of this study is to evaluate the serum dehydroepiandrosterone sulfate in subclinical hypercortisolism